Bottom line
How has NEMRX performed?
As of Dec 31, 2024, NEMRX returned +12.2% over the past year, −1.0% a year over five years, +2.2% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $12,400. Its five-year return beat 8% of emerging markets funds we track. Its best quarter was +18.1% and its worst −23.7%.
Updated Dec 31, 2024
NEMRX annual returns by year
| Year | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| NEMRX | +12.2% | +4.0% | −24.3% | −4.0% | +12.6% | +18.2% | −17.8% | +40.6% | +8.5% | −12.1% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in NEMRX
$10,000 invested at the start of 2015 would have been worth about $12,400 by the end of 2024, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2024 | +12.2% | $12,419 |
| 2023 | +4.0% | $11,073 |
| 2022 | −24.3% | $10,649 |
| 2021 | −4.0% | $14,077 |
| 2020 | +12.6% | $14,666 |
| 2019 | +18.2% | $13,026 |
| 2018 | −17.8% | $11,021 |
| 2017 | +40.6% | $13,415 |
| 2016 | +8.5% | $9,541 |
| 2015 | −12.1% | $8,794 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| NEMRX | +12.2% | −1.0% | +2.2% | — |
| Emerging Markets median | +27.8% | +3.0% | +7.6% | — |
Source: Prospectus as of Dec 31, 2024; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending May 31, 2026, NEMRX returned −9.10%, +4.91%, −1.24% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.